M. Lazanas

发表

Comparative evaluation of the QUANTIPLEX HIV-1 RNA 2.0 and 3.0 (bDNA) assays and the AMPLICOR HIV-1 MONITOR v1.5 test for the quantitation of human immunodeficiency virus type 1 RNA in plasma.

D. Paraskevis, A. Hatzakis, C. Anastassopoulou, 2001, Journal of virological methods.

The Role of Macrolides for the Management of Community-Acquired Pneumonia and Pneumonia by the Novel Coronavirus SARS-CoV-2 (COVID-19): A Position Paper by Four Medical Societies from Greece

Christos G Gogos, E. Giamarellos‐Bourboulis, G. Daikos, 2021, Infectious Diseases and Therapy.

Genotypic characterization of human immunodeficiency virus type 1 in Greece. Multicentre Study on HIV-1 Heterogeneity.

A. Hatzakis, G. Nasioulas, V. Paparizos, 1998, AIDS research and human retroviruses.

Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy.

L. Kostrikis, A. Hatzakis, G. Pavlakis, 2002, Nature Reviews Immunology.

Moderate Hyperhomocysteinemia along with Increased Levels of Vitamin B12 in a 21-Year-Old Male with the Sanfilippo Syndrome: A Case Report

M. Detopoulou, C. Kollia, P. Detopoulou, 2020, Case Reports in Clinical Nutrition.

Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)

Anne M Johnson, Hansjakob Furrer, Peter Reiss, 2013, PLoS medicine.

Estimation of the Direct Cost of HIV-Infected Patients in Greece on an Annual Basis.

K. Athanasakis, J. Kyriopoulos, N. Boubouchairopoulou, 2014, Value in health regional issues.

Low-dose IFN-alpha monotherapy in treatment-naive individuals with HIV-1 infection: evidence of potent suppression of viral replication.

D. Paraskevis, A. Hatzakis, C. Anastassopoulou, 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Economic Recession and Emergence of an HIV-1 Outbreak among Drug Injectors in Athens Metropolitan Area: A Longitudinal Study

A. Hatzakis, S. Friedman, A. Fotiou, 2013, PloS one.

A Nationwide Study about the Dispersal Patterns of the Predominant HIV-1 Subtypes A1 and B in Greece: Inference of the Molecular Transmission Clusters

A. Hatzakis, E. Kostaki, D. Paraskevis, 2020, Viruses.

Comparison of three current viral load assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma.

A. Hatzakis, C. Anastassopoulou, V. Sypsa, 2004, Journal of virological methods.

HIV-1 outbreak among injecting drug users in Greece, 2011: a preliminary report.

A. Hatzakis, J. Kremastinou, D. Paraskevis, 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Increasing prevalence of HIV-1 subtype A in Greece: estimating epidemic history and origin.

Gkikas Magiorkinis, Oliver G Pybus, Angelos Hatzakis, 2007, The Journal of infectious diseases.

Transmission Dynamics of HIV-1 Drug Resistance among Treatment-Naïve Individuals in Greece: The Added Value of Molecular Epidemiology to Public Health

E. Maltezos, A. Hatzakis, E. Kostaki, 2017, Genes.

Effect of HIV type 1 subtype on virological and immunological response to combination antiretroviral therapy: evidence for a more rapid viral suppression for subtype A than subtype B-infected Greek individuals.

A. Hatzakis, G. Touloumi, A. Antoniadou, 2013, AIDS research and human retroviruses.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013.

Anne M Johnson, A. Mocroft, O. Kirk, 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Prevalence of drug resistance among HIV-1 treatment-naive patients in Greece during 2003-2015: Transmitted drug resistance is due to onward transmissions.

E. Maltezos, G. Magiorkinis, A. Hatzakis, 2017, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Virological and Immunological Response to HAART Therapy in a Community-Based Cohort of HIV-1-Positive Individuals

A. Hatzakis, G. Touloumi, A. Antoniadou, 2001, HIV clinical trials.

Mutations associated with genotypic resistance to antiretroviral therapy in treatment naïve HIV-1 infected patients in Greece.

G. Magiorkinis, A. Hatzakis, D. Paraskevis, 2002, Virus research.

Dating the Origin and Estimating the Transmission Rates of the Major HIV-1 Clusters in Greece: Evidence about the Earliest Subtype A1 Epidemic in Europe

E. Maltezos, G. Magiorkinis, A. Hatzakis, 2022, Viruses.

Access of People Living with HIV to Testing Services in Greece: A Challenge for Equity in Care

N. Dedes, K. Souliotis, D. Sifaki-Pistolla, 2022, International journal of environmental research and public health.

Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy

L. Kostrikis, A. Hatzakis, G. Pavlakis, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece.

E. Magiorkinis, A. Hatzakis, D. Paraskevis, 2005, Virus research.

Cost Estimation of Hiv Infection in Greece: Data from an Infectious Diseases Unit.

K. Athanasakis, J. Kyriopoulos, N. Boubouchairopoulou, 2014, Value in Health.

Estimation of the determinants for HIV late presentation using the traditional definition and molecular clock‐inferred dates: Evidence that older age, heterosexual risk group and more recent diagnosis are prognostic factors

G. Magiorkinis, A. Hatzakis, P. Lagiou, 2022, HIV medicine.

Molecular characterization of a complex, recombinant human immunodeficiency virus type 1 (HIV-1) isolate (A/G/J/K/?): evidence to support the existence of a novel HIV-1 subtype.

A. Vandamme, G. Magiorkinis, D. Paraskevis, 2001, The Journal of general virology.

Earlier treatment initiation is associated with a decreased number of HIV-1 subtype A1 transmissions in Greece

E. Maltezos, G. Magiorkinis, A. Hatzakis, 2020, Sexually Transmitted Infections.

Appearance of a single amino acid insertion at position 33 in HIV type 1 protease under a lopinavir-containing regimen, associated with reduced protease inhibitor susceptibility.

A. Vandamme, A. Molla, G. Magiorkinis, 2011, AIDS research and human retroviruses.